OAB-049: Poor post-vaccination anti-SARS-CoV-2-antibody response in patients with Multiple Myeloma correlates with low CD19+ B-lymphocyte count and anti-CD38 treatment

BACKGROUND: Up to now, only few data are available regarding the efficacy of anti-SARS-CoV-2 vaccines in patients with plasma cell neoplasia. This ongoing observational study aimed to describe the level of post-vaccination anti-SARS-CoV-2-antibodies depending on B lymphocyte count, current therapy,...

Descripción completa

Detalles Bibliográficos
Autores principales: Ghandili, Susanne, Schönlein, Martin, Lütgehetmann, Marc, Wiesch, Julian Schulze zur, Becher, Heiko, Bokemeyer, Carsten, Sinn, Marianne, Weisel, Katja, Leypoldt, Lisa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Inc. 2021
Materias:
Oral Presentations
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8580176/
http://dx.doi.org/10.1016/S2152-2650(21)02123-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8580176/
http://dx.doi.org/10.1016/S2152-2650(21)02123-6

Ejemplares similares